AU5577201A - Immunogenic pneumococcal protein and vaccine compositions thereof - Google Patents

Immunogenic pneumococcal protein and vaccine compositions thereof

Info

Publication number
AU5577201A
AU5577201A AU5577201A AU5577201A AU5577201A AU 5577201 A AU5577201 A AU 5577201A AU 5577201 A AU5577201 A AU 5577201A AU 5577201 A AU5577201 A AU 5577201A AU 5577201 A AU5577201 A AU 5577201A
Authority
AU
Australia
Prior art keywords
vaccine compositions
pneumococcal protein
immunogenic pneumococcal
immunogenic
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU5577201A
Other languages
English (en)
Inventor
Scott Koenig
Leslie S Johnson
John E Amadou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune LLC filed Critical MedImmune LLC
Publication of AU5577201A publication Critical patent/AU5577201A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU5577201A 2000-04-27 2001-04-27 Immunogenic pneumococcal protein and vaccine compositions thereof Pending AU5577201A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20007400P 2000-04-27 2000-04-27
PCT/US2001/013828 WO2001081380A2 (en) 2000-04-27 2001-04-27 Immunogenic pneumococcal protein and vaccine compositions thereof

Publications (1)

Publication Number Publication Date
AU5577201A true AU5577201A (en) 2001-11-07

Family

ID=22740214

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001255772A Ceased AU2001255772B2 (en) 2000-04-27 2001-04-27 Immunogenic pneumococcal protein and vaccine compositions thereof
AU5577201A Pending AU5577201A (en) 2000-04-27 2001-04-27 Immunogenic pneumococcal protein and vaccine compositions thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001255772A Ceased AU2001255772B2 (en) 2000-04-27 2001-04-27 Immunogenic pneumococcal protein and vaccine compositions thereof

Country Status (6)

Country Link
US (1) US6689369B2 (enExample)
EP (1) EP1278856A2 (enExample)
JP (1) JP2003530872A (enExample)
AU (2) AU2001255772B2 (enExample)
CA (1) CA2407455A1 (enExample)
WO (1) WO2001081380A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
IL138798A0 (en) * 1998-04-07 2001-10-31 Medimmune Inc Vaccines and antibodies against bacterial pneumococcal infection
CA2444133A1 (en) 2001-04-16 2002-10-24 Wyeth Holdings Corporation Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
PT2268618E (pt) 2008-03-03 2015-10-12 Novartis Ag Compostos e composições moduladores da actividade tlr
AU2010258677B2 (en) 2009-06-10 2016-10-06 Glaxosmithkline Biologicals S.A. Benzonaphthyridine-containing vaccines
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
JP5988492B2 (ja) 2009-09-02 2016-09-07 ノバルティス アーゲー Ｔｌｒ活性モジュレーターを含む免疫原性組成物
WO2011030218A1 (en) 2009-09-10 2011-03-17 Novartis Ag Combination vaccines against respiratory tract diseases
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
WO2011084549A1 (en) 2009-12-15 2011-07-14 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
EA031379B1 (ru) 2010-03-23 2018-12-28 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
CN104519910B (zh) 2012-03-07 2017-05-03 诺华股份有限公司 肺炎链球菌抗原的含佐剂制剂
ES2670863T3 (es) 2013-02-01 2018-06-01 Glaxosmithkline Biologicals Sa Administración intradérmica de composiciones inmunológicas que comprenden agonistas del receptor de tipo Toll
US11458151B2 (en) 2018-02-12 2022-10-04 Inimmune Corporation Toll-like receptor ligands
JP2023547677A (ja) 2020-11-04 2023-11-13 エリゴ・バイオサイエンス キューティバクテリウム・アクネス組換えファージ、その産生方法及び使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000514308A (ja) * 1996-08-16 2000-10-31 スミスクライン・ビーチャム・コーポレイション 新規原核生物ポリヌクレオチド、ポリペプチドおよびそれらの使用
EP0942983B2 (en) * 1996-10-31 2014-09-10 Human Genome Sciences, Inc. Streptococcus pneumoniae antigens and vaccines

Also Published As

Publication number Publication date
WO2001081380A3 (en) 2002-02-28
AU2001255772B2 (en) 2006-06-29
US6689369B2 (en) 2004-02-10
CA2407455A1 (en) 2001-11-01
EP1278856A2 (en) 2003-01-29
WO2001081380A2 (en) 2001-11-01
JP2003530872A (ja) 2003-10-21
US20030166844A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
IL151942A0 (en) Compositions and methods for enhancing immunogenicity of antigens
AU5577201A (en) Immunogenic pneumococcal protein and vaccine compositions thereof
AP2002002700A0 (en) Vaccine composition
HUP0302117A3 (en) Vaccine composition
GB0020089D0 (en) Vaccine Composition
GB0023008D0 (en) Improvements in vaccination
PL358335A1 (en) Polyglutamic acid-camptothecin conjugates and methods of preparation
GB0020953D0 (en) Vaccine
HUP0301092A3 (en) Vaccine
IL155072A0 (en) Vaccine
EP1309602A4 (en) MALARIA IMMUNOGEN AND VACCINE
IL148247A (en) Vaccine and its uses
AU7013501A (en) Methods and composition for oral vaccination
PL362964A1 (en) Vaccine
GB0129007D0 (en) Adjuvanted antigenic meningococcal compositions
AU2151902A (en) Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
GB2370772B (en) Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis
GB0014288D0 (en) Vaccine
AU9567201A (en) Vaccine composition and stabilisation method
HUP0401157A3 (en) Methyl-thieno-benzodiazepine lyophilized formulation, its preparation and use
GB0105606D0 (en) Immunogens and vaccines and their preparation and use
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
GB0025694D0 (en) Vaccine
GB0003082D0 (en) Vaccine